Experimental drug shows promise for advanced MS, delaying disability. Learn how Black Americans may benefit & why clinical ...

Results of the Phase III HERCULES trial suggest the first potential treatment option for a form of multiple sclerosis.

The Phase 4 ENABLE study is set to be first in the U.S. to collect real-world safety and efficacy data of Briumvi for ...

Tolebrutinib, a novel BTK inhibitor that targets neuroinflammation, slowed disability progression by 31% in nrSPMS, a phase 3 ...

A mortician in Mississippi is facing charges after he allegedly put human bodies inside a storage unit. Albert Creath, 31, the former owner of now-defunct Creath Memorial Services, allegedly used ...

The following is a summary of “Effect of patient-centered empowerment program through telenursing on self-management in ...

EDITORIAL NOTE: This is the first of two stories from an exclusive interview with Mississippi Gov. Tate Reeves on the successes of the state's economic development strategy and where he sees the ...

A Cleveland Clinic-led clinical trial of tolebrutinib, an investigational oral Bruton's tyrosine kinase inhibitor, a group of ...

Patients with relapsing MS treated with tolebrutinib vs teriflunomide had a clear reduction in disability accumulation with ...

WEDNESDAY, April 9, 2025 (HealthDay News) -- An experimental drug can help patients with advanced multiple sclerosis (MS) ...